the microsampling blog

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In the US, the device is not for use with saliva samples intended for clinical DNA testing. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some content.

is dried blood a biohazard?

by Neoteryx | 2 min read

neoteryx-biohazard-2.jpgWorking with traditional wet blood specimens has always raised safety concerns and posed logistical challenges. Blood sample storage and cold chain shipping require navigating an increasingly complicated maze of regulatory issues. It's no wonder that dried blood spotting has emerged in the last few decades as a preferable alternative in many cases.

Working with wet blood, collected from traditional venipuncture methods, brings with it the full range of obligations associated with handling and disposing of biohazardous materials – not to mention the significant risks. By contrast, dried blood is simply not as dangerous, and is subject to far more liberal requirements.

The CDC recently updated its guidelines around handling and shipping dried blood specimens. While important safety precautions must be recognized and put in place, the expectations for dealing with dried capillary blood specimens are nowhere near as rigorous as those for wet blood and other serious biohazards. Clearly, dried blood is not a biohazard in the same way that wet blood is.

However, working with dried blood has traditionally posed its own unique challenges. Data generated from DBS cards and filter paper has traditionally not compared to the "gold standard" associated with wet blood, chiefly because of the hematocrit bias. Dried blood spotting has required upheaval of lab workflows, and the costs and logistical difficulties of automation have proved prohibitive for many medium- to high-throughput labs.

vams-capillary-dry-blood-collection-devices_v2.jpgIn response to these frustrations, Volumetric Absorptive Microsampling (VAMS™) has emerged as the next generation of dried blood spotting technology. It facilitates the simple collection of volumetrically accurate, quantitative dried blood samples with a user-friendly device that resembles a Q-Tip. Because they are stable and precise, the hematocrit bias is effectively equalized, and these samples can produce a wealth of data that correlates with that generated from wet blood specimens.

Per CDC guidelines, taking and sending capillary blood samples is easier, but the process is not entirely cut and dried. (Pardon the pun.) Fortunately, Blood Collection Kits (available from Neoteryx) include detailed instructions and all the accessories needed for collecting volumetrically accurate dried blood samples anywhere, at any time. Almost anyone can do it, with minimal training. And these kits can be fully customized to meet nearly any preference or requirement.

If you know it's time to make the switch to dried blood, but you're not sure how to get started, our microsampling specialists can make the process easy and rewarding.

Click to download our microsampling case studies on those who switched from venipuncture to capillary blood sampling with the Mitra microsampler

Originally published Apr 9, 2018 6:06:00 AM, updated on October 11, 2019

Comments

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog